Portugal, April 17 -- Portugal based Novartis Farma - Produtos Farmaceuticos has secured contract from Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE for Pharmaceutical products Tisagenlecleucel 12 x10e6 - 6 x10e8 celulas Disp inj Fr 50 ml IV. The value of the contract is worth 631892500 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....